Empagliflozin and Linagliptin
Empagliflozin and Linagliptin comes in 2 pill versions in our database, in 2 strengths, from 1 manufacturer. Check the imprint to tell them apart.
Empagliflozin and Linagliptin pill images
10 mg / 5 mg 1 pill
25 mg / 5 mg 1 pill
What is Empagliflozin and Linagliptin used for?
Empagliflozin and Linagliptin is used for type 2 diabetes.
- Medicine type
- Diabetes medicine (SGLT2 inhibitor); diabetes medicine (DPP-4 inhibitor)
Official uses from the US prescribing label
GLYXAMBI is a combination of empagliflozin and linagliptin indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Empagliflozin is indicated to reduce the risk of cardiovascular (CV) death in adults with type 2 diabetes mellitus and established CV disease.
Limitations of Use
GLYXAMBI is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients.
GLYXAMBI has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using GLYXAMBI.
GLYXAMBI is not recommended for use to improve glycemic control in adults with type 2 diabetes mellitus with an eGFR less than 30 mL/min/1.73 m2. GLYXAMBI is likely to be ineffective in this setting based upon its mechanism of action.
From the FDA-approved label on DailyMed (published Feb 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.